Protocol Ledger

NCT04078737 · Phase III · COMPLETED

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II

Interventional Phase III clinical trial protocol NCT04078737 sponsored by Beijing Tiantan Hospital in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-09-23 Enrollment: 6,412 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04078737
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)6,412 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04078737
Protocol FieldVerified Registry Value
NCT IdentifierNCT04078737
Consolidated Lead SponsorBeijing Tiantan Hospital
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment6,412 participants (ACTUAL)
Registered Start Date2019-09-23
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI